| Pancreatic adenocarcinoma, version 2.2017, NCCN clinical practice guidelines in oncology MA Tempero, MP Malafa, M Al-Hawary, H Asbun, A Bain, SW Behrman, ... Journal of the National Comprehensive Cancer Network 15 (8), 1028-1061, 2017 | 971 | 2017 |
| Pancreatic adenocarcinoma, version 2.2021, NCCN clinical practice guidelines in oncology MA Tempero, MP Malafa, M Al-Hawary, SW Behrman, AB Benson, ... Journal of the National Comprehensive Cancer Network 19 (4), 439-457, 2021 | 690 | 2021 |
| Mortality by stage for right-versus left-sided colon cancer: analysis of surveillance, epidemiology, and end results–Medicare data JM Weiss, PR Pfau, ES O'Connor, J King, N LoConte, G Kennedy, ... Journal of Clinical Oncology 29 (33), 4401, 2011 | 495 | 2011 |
| Adjuvant chemotherapy for stage II colon cancer with poor prognostic features ES O'Connor, DY Greenblatt, NK LoConte, RE Gangnon, JI Liou, ... Journal of clinical oncology 29 (25), 3381, 2011 | 488 | 2011 |
| Preoperative modified FOLFIRINOX treatment followed by capecitabine-based chemoradiation for borderline resectable pancreatic cancer: alliance for clinical trials in oncology … MHG Katz, Q Shi, SA Ahmad, JM Herman, RW Marsh, E Collisson, ... JAMA surgery 151 (8), e161137-e161137, 2016 | 429 | 2016 |
| NCCN guidelines insights: pancreatic adenocarcinoma, version 1.2019: featured updates to the NCCN guidelines MA Tempero, MP Malafa, EG Chiorean, B Czito, C Scaife, AK Narang, ... Journal of the National Comprehensive Cancer Network 17 (3), 202-210, 2019 | 374 | 2019 |
| Alcohol and cancer: a statement of the American Society of Clinical Oncology NK LoConte, AM Brewster, JS Kaur, JK Merrill, AJ Alberg Journal of Clinical Oncology 36 (1), 83-93, 2018 | 360 | 2018 |
| Perceived stigma, self-blame, and adjustment among lung, breast and prostate cancer patients NM Else-Quest, NK LoConte, JH Schiller, JS Hyde Psychology and Health 24 (8), 949-964, 2009 | 332 | 2009 |
| Report of a multicenter phase II trial testing a combination of biweekly bevacizumab and daily erlotinib in patients with unresectable biliary cancer: a phase II Consortium study SJ Lubner, MR Mahoney, JL Kolesar, NK LoConte, GP Kim, HC Pitot, ... Journal of Clinical Oncology 28 (21), 3491, 2010 | 312 | 2010 |
| Results from a phase IIb, randomized, multicenter study of GVAX pancreas and CRS-207 compared with chemotherapy in adults with previously treated metastatic pancreatic … DT Le, VJ Picozzi, AH Ko, ZA Wainberg, H Kindler, A Wang-Gillam, ... Clinical Cancer Research 25 (18), 5493-5502, 2019 | 229 | 2019 |
| Readmission after colectomy for cancer predicts one-year mortality DY Greenblatt, SM Weber, ES O'Connor, NK LoConte, JI Liou, MA Smith Annals of surgery 251 (4), 659-669, 2010 | 222 | 2010 |
| Global epidemiology, prevention, and management of hepatocellular carcinoma LY Mak, V Cruz-Ramón, P Chinchilla-López, HA Torres, NK LoConte, ... American Society of Clinical Oncology Educational Book 38, 262-279, 2018 | 216 | 2018 |
| Phase III prospective randomized comparison trial of depot octreotide plus interferon alfa-2b versus depot octreotide plus bevacizumab in patients with advanced carcinoid … JC Yao, KA Guthrie, C Moran, JR Strosberg, MH Kulke, JA Chan, ... Journal of Clinical Oncology 35 (15), 1695, 2017 | 214* | 2017 |
| A phase I study of FOLFIRINOX plus IPI-926, a hedgehog pathway inhibitor, for advanced pancreatic adenocarcinoma AH Ko, N LoConte, MA Tempero, EJ Walker, RK Kelley, S Lewis, ... Pancreas 45 (3), 370-375, 2016 | 210 | 2016 |
| Assessment of guilt and shame in patients with non–small-cell lung cancer compared with patients with breast and prostate cancer NK LoConte, NM Else-Quest, J Eickhoff, J Hyde, JH Schiller Clinical lung cancer 9 (3), 171-178, 2008 | 209 | 2008 |
| Clinical cancer advances 2020: annual report on progress against cancer from the American Society of Clinical Oncology MJ Markham, K Wachter, N Agarwal, MM Bertagnolli, SM Chang, W Dale, ... Journal of Clinical Oncology 38 (10), 1081, 2020 | 146 | 2020 |
| Predictors of short-term postoperative survival after elective colectomy in colon cancer patients≥ 80 years of age HB Neuman, JM Weiss, G Leverson, ES O’Connor, DY Greenblatt, ... Annals of surgical oncology 20, 1427-1435, 2013 | 120 | 2013 |
| A pilot phase II study of valproic acid for treatment of low‐grade neuroendocrine carcinoma TA Mohammed, KD Holen, R Jaskula‐Sztul, D Mulkerin, SJ Lubner, ... The oncologist 16 (6), 835-843, 2011 | 96 | 2011 |
| Surgical treatment of colon cancer in patients aged 80 years and older: analysis of 31,574 patients in the SEER‐Medicare database HB Neuman, ES O'Connor, J Weiss, NK LoConte, DY Greenblatt, ... Cancer 119 (3), 639-647, 2013 | 93 | 2013 |
| Precision medicine in colorectal cancer: the molecular profile alters treatment strategies NH Tran, LL Cavalcante, SJ Lubner, DL Mulkerin, NK LoConte, L Clipson, ... Therapeutic advances in medical oncology 7 (5), 252-262, 2015 | 82 | 2015 |
Sam LubnerUniversity of Wisconsin Carbone Cancer CenterVerified email at medicine.wisc.edu
